EZZ Life Sciences (EZZ) Chair Glenn Cross discusses impressive FY23 results in TV interview
30 August 2023 Glenn completed a successful live TV interview. EZZ Life Sciences (EZZ) Chair Glenn Cross discusses impressive FY23 results, highlighting a 176% net profit increase to nearly $4 million and a 147% revenue surge. The growth is attributed…